Related articles:

Agios Pharmaceuticals Inc.: Agios Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key 2017 Milestones
February 16, 2017
February 16, 2017

Agios Pharmaceuticals Inc.: Agios to Webcast Conference Call of Fourth Quarter and Full Year 2016 Financial Results on February 16, 2017
February 09, 2017
February 9, 2017

Agios Pharmaceuticals Inc.: Agios Appoints Andrew Hirsch as Chief Financial Officer
August 16, 2016
August 16, 2016

Agios Pharmaceuticals Inc.: Agios Reports Second Quarter 2016 Financial Results
August 04, 2016
August 4, 2016

Agios Pharmaceuticals Inc.: Agios to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016
July 28, 2016
July 28, 2016

Agios Pharmaceuticals Inc.: AG-348 Achieves Proof-of-Concept in Ongoing Phase 2 DRIVE-PK Study and Demonstrates Rapid and Sustained Hemoglobin Increases in Adults with Pyruvate Kinase Deficiency
June 11, 2016
June 11, 2016

Agios Pharmaceuticals Inc.: Agios Reports Initial Data from Phase 1 Study of AG-519 in Healthy Volunteers
June 09, 2016
June 9, 2016

Agios Pharmaceuticals Inc.: Agios to Host Conference Call from the 21st Congress of the European Hematology Association
June 01, 2016
June 1, 2016

Agios Pharmaceuticals Inc.: Agios to Present Clinical and Preclinical Data from PKR Activators AG-348 and AG-519 at the 21st Congress of the European Hematology Association
May 19, 2016
May 19, 2016

Agios Pharmaceuticals Inc.: Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement
May 17, 2016
May 17, 2016

Agios Pharmaceuticals Inc.: Agios Updates 2016 Financial Guidance
May 17, 2016

Agios Pharmaceuticals Inc.: Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones
February 18, 2016
February 18, 2016

Agios Pharmaceuticals Inc.: Agios to Webcast Conference Call of Fourth Quarter and Full Year 2015 Financial Results on February 18, 2016
February 11, 2016
February 11, 2016

Agios Pharmaceuticals Inc.: Agios Appoints Steve Hoerter as Chief Commercial Officer
February 08, 2016
February 8, 2016

Agios Pharmaceuticals Inc.: Agios Reports Third Quarter 2015 Financial Results
November 05, 2015
November 5, 2015

Agios Pharmaceuticals Inc.: Agios to Webcast Conference Call of Third Quarter 2015 Financial Results on November 5, 2015
October 29, 2015
October 29, 2015

Agios Pharmaceuticals Inc.: Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress
August 06, 2015
August 6, 2015

Agios Pharmaceuticals Inc.: Agios to Webcast Conference Call of Second Quarter 2015 Financial Results on August 6, 2015
July 30, 2015
July 30, 2015

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals to Webcast Conference Call of First Quarter 2015 Financial Results on May 7, 2015
April 28, 2015
April 28, 2015

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results
February 17, 2015
February 17, 2015

Agios Pharmaceuticals Inc.: Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration
January 12, 2015
January 12, 2015

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors
December 09, 2014
December 9, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
November 07, 2014
November 7, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014
October 27, 2014
October 27, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results
August 07, 2014
August 7, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014
July 28, 2014
July 28, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Announces that Celgene Exercised its Option to License AG-221 Under Global Strategic Collaboration
June 13, 2014
June 13, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Reports First Quarter 2014 Financial Results
May 08, 2014
May 8, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals to Webcast Conference Call of First Quarter 2014 Financial Results on May 8, 2014
April 30, 2014
April 30, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Announces Pricing of Public Offering of Common Stock
April 23, 2014
April 23, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Announces Proposed Offering of Common Stock
April 21, 2014
April 21, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
March 06, 2014
March 6, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals to Webcast Conference Call Discussing Fourth Quarter and Full Year 2013 Financial Results on March 6, 2014
February 27, 2014
February 27, 2014

Agios Pharmaceuticals Inc.: Agios Pharmaceuticals Exercises Option to U.S. Development and Commercialization Rights for IDH1 Program under Celgene Collaboration
February 03, 2014
February 3, 2014

Pin It on Pinterest

Share This